Piotr Lacina

Wroclaw, DS, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Microbiota and mycobiota in chronic inflammatory demyelinating polyneuropathy: clinical and pathophysiological correlations.

Microbiota and mycobiota in chronic inflammatory demyelinating polyneuropathy: clinical and pathophysiological correlations.

Journal: Frontiers in molecular neuroscience
Published: February 02, 2026

NCR1 and NCR3 Expression and Genetic Polymorphism are Associated with CMV Infection after Allogeneic Haematopoietic Stem Cell Transplantation.

NCR1 and NCR3 Expression and Genetic Polymorphism are Associated with CMV Infection after Allogeneic Haematopoietic Stem Cell Transplantation.

Journal: Archivum immunologiae et therapiae experimentalis
Published: January 07, 2026

Genetic and metabolic inflammation signatures in chronic inflammatory demyelinating polyneuropathy: the role of IL18 polymorphisms and short-chain fatty acids.

Genetic and metabolic inflammation signatures in chronic inflammatory demyelinating polyneuropathy: the role of IL18 polymorphisms and short-chain fatty acids.

Journal: Frontiers in molecular neuroscience
Published: November 03, 2025

Pharmacogenetics of graft-versus-host disease: a path to personalized medicine.

Pharmacogenetics of graft-versus-host disease: a path to personalized medicine.

Journal: Pharmacogenomics
Published: August 07, 2025

miR-302d-3p expression and genotype are associated with CMV replication after allogeneic haematopoietic stem cell transplantation.

miR-302d-3p expression and genotype are associated with CMV replication after allogeneic haematopoietic stem cell transplantation.

Journal: Human immunology
Published: May 07, 2025

ILT-2 and ILT-4 expression and donor genotype as factors associated with HSCT outcome.

ILT-2 and ILT-4 expression and donor genotype as factors associated with HSCT outcome.

Journal: Clinical immunology (Orlando, Fla.)
Published: May 06, 2025

Polymorphisms in Necroptosis Pathway Genes: Novel Prognostic Markers for Multiple Myeloma Treatment Outcomes.

Polymorphisms in Necroptosis Pathway Genes: Novel Prognostic Markers for Multiple Myeloma Treatment Outcomes.

Journal: International journal of molecular sciences
Published: April 13, 2025

Telomere length and telomerase reverse transcriptase gene polymorphism as potential markers of complete chimerism and GvHD development after allogeneic haematopoietic stem cell transplantation.

Telomere length and telomerase reverse transcriptase gene polymorphism as potential markers of complete chimerism and GvHD development after allogeneic haematopoietic stem cell transplantation.

Journal: Journal of cancer research and clinical oncology
Published: February 12, 2025

Soluble MICA concentrations and genetic variability of MICA and its NKG2D receptor as factors affecting Graft-versus-Host Disease development after allogeneic haematopoietic stem cell transplantation.

Soluble MICA concentrations and genetic variability of MICA and its NKG2D receptor as factors affecting Graft-versus-Host Disease development after allogeneic haematopoietic stem cell transplantation.

Journal: Human immunology
Published: July 09, 2024

Effect of NK cell receptor genetic variation on allogeneic stem cell transplantation outcome and in vitro NK cell cytotoxicity.

Effect of NK cell receptor genetic variation on allogeneic stem cell transplantation outcome and in vitro NK cell cytotoxicity.

Journal: Scientific reports
Published: March 12, 2024

Donor genetic determinant of thymopoiesis, rs2204985, and stem cell transplantation outcome in a multipopulation cohort.

Donor genetic determinant of thymopoiesis, rs2204985, and stem cell transplantation outcome in a multipopulation cohort.

Journal: Human immunology
Published: December 14, 2023

Polymorphisms within genes encoding Ikaros family proteins IKZF1 and IKZF3 in multiple myeloma patients treated with thalidomide.

Polymorphisms within genes encoding Ikaros family proteins IKZF1 and IKZF3 in multiple myeloma patients treated with thalidomide.

Journal: Dental and medical problems
Published: July 20, 2023
Showing 1-12 of 32

Last Updated: 09/26/2026